Merck & Co Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Merck & Co Inc
TickerMRK
CIK #0000310158
CUSIP58933Y105
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Merck Drive PO Box 100, Whitehouse Station, NJ 08889-0100
Source [EDGAR]
CIK Filing 2011 - 2025
[0000310158] 10-K
[0000310158] 10-Q
[0000310158] 13F-HR
[0000310158] 3
[0000310158] 4
[0000310158] 5
[0000310158] 8-K
[0000310158] SC 13D
[0000310158] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Merck & Co Inc Personalis Inc [2024-12-23] 0.0
Merck & Co Inc Evaxion Biotech A/S [2024-01-23] 11.4
Merck & Co Inc 4D Pharma PLC [2022-02-02] 0.0
Merck & Co Inc Pandion Therapeutics Inc [2021-03-04] 39.99
Merck & Co Inc Yumanity Therapeutics Inc [2021-01-04] 0.0
Merck & Co Inc Arqule Inc [2019-12-16] 12.6
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09] 19.9
Merck & Co Inc Alector Inc [2019-02-14] 5.1
Merck & Co Inc Sutro Biopharma Inc [2018-10-04] 11.9
Merck & Co Inc Menlo Therapeutics Inc [2018-02-14] 5.41
Merck & Co Inc Spero Therapeutics Inc [2017-11-15] 6.5
Merck & Co Inc KalVista Pharmaceuticals Inc [2017-10-16] 0.9
Capital World Investors Merck & Co Inc [2017-02-13] 5.1
Merck & Co Inc BeiGene Ltd [2016-02-12] 7.4
Vanguard Group Inc Merck & Co Inc [2015-02-11] 5.46
Merck & Co Inc Idenix Pharmaceuticals Inc [2014-06-13] 14.9
Wellington Management Co LLP Merck & Co Inc [2014-02-14] 5.27
Form 3/4/5 Filer 2011 - 2025
Merck & Co., Inc.
Guindo Chirfi
Williams David Michael
Coe Mary Ellen
Glocer Thomas H
Seidman Christine E
Craig Pamela J.
Lavizzo-Mourey RISA J
Karsanbhai Surendralal Lanca
Baker Douglas M Jr
Warden Kathy J
Thulin Inge G
Russo Patricia F
Rothman Paul
Mayo Stephen
Smart Dalton E. III
Larson Betty D
Romanelli Joseph
Oosthuizen Johannes Jacobus
Chattopadhyay Sanat
DeLuca Richard R.
Davis Robert M
Li Dean Y
Zachary Jennifer
Downing Cristal N
Litchfield Caroline
Merck Sharp & Dohme LLC
Personalis, Inc.
Klobuchar Michael A
Wendell Peter C
Harpoon Therapeutics, Inc.
Mizell Steven
LeCointe-Cephas Lisa
Karachun Rita A
Frazier Kenneth C
Garay Arpa
Gerberding Julie L.
Clyburn Frank
Organon & Co.
Brun Leslie A
Pandion Therapeutics, Inc.
Nally Michael
Fleming Michael
Cech Thomas R
Weeks Wendell P
Perlmutter Roger M
Lazarus Rochelle B
Merck Sharp & Dohme Corp.
Arqule Inc
Scholefield James H
NGM Biopharmaceuticals Inc
Noseworthy John H
Schechter Adam H
Watson Ashley
Sutro Biopharma Inc
Thompson Craig B.
Graddick Weir Mirian M
Holston Michael J
Opgen Inc
Merck Global Health Innovation Fund, LLC
VYNE Therapeutics Inc.
Represas Carlos E
Kidder C Robert
Ambrose Adele D
Golestani Clark
Rosenblatt Michael
Harrison William B Jr
Deese Willie A
BeOne Medicines Ltd.
Merck Sharp & Dohme Research GmbH
Kuhlik Bruce N
Heller Bridgette P
Canan John
Kellogg Peter N
Do Cuong V
Kim Peter S
Bowles Richard S III
Scalet J Chris
Tatlock Anne M
Kelley Willam N
Goldstone Steven F
Kohan Raul E
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 240,321,092
BlackRock, Inc. [2025-06-30] SOLE 196,704,938 218,340,832
State Street Corp [2025-06-30] DFND 66,570,117 118,493,864
Wellington Management Group LLP [2025-06-30] DFND 0 76,856,492
Geode Capital Management LLC [2025-06-30] DFND 58,896,493 58,952,681
Charles Schwab Investment Management Inc [2025-06-30] SOLE 53,611,498 53,699,088
Morgan Stanley [2025-06-30] DFND 21,677,371 44,200,694
Norges Bank [2025-06-30] SOLE 36,111,289 36,111,289
Bank of America Corp /DE/ [2025-06-30] DFND 7,516,905 32,710,434
FMR LLC [2025-06-30] DFND 21,508,479 31,566,125
JPMorgan Chase & Co [2025-06-30] DFND 25,576,647 31,344,592
Northern Trust Corp [2025-06-30] DFND 27,282,406 27,795,508
Franklin Resources Inc [2025-06-30] DFND 26,848,567 27,028,765
Fisher Asset Management LLC [2025-06-30] DFND 21,892,163 25,013,697
Bank of New York Mellon Corp [2025-06-30] DFND 17,592,385 21,232,329
Legal & General Group Plc [2025-06-30] DFND 17,703,221 19,503,045
Arrowstreet Capital Limited Partnership [2025-06-30] DFND 16,231,665 19,456,096
Goldman Sachs Group Inc [2025-06-30] DFND 17,538,580 18,925,853
UBS Group AG [2025-06-30] DFND 7,958,257 18,325,084
Invesco Ltd. [2025-06-30] DFND 0 17,023,170
Deutsche Bank AG [2025-06-30] DFND 9,053,104 16,815,302
Amundi [2025-06-30] DFND 16,375,026 16,532,657
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] DFND 7,038,216 13,245,588
Ameriprise Financial Inc [2025-06-30] DFND 0 13,198,450
Susquehanna International Group LLP [2025-06-30] OTR 1,899,857 12,851,057
Vanguard Group Inc [2025-06-30] DFND 8,592 12,593,334
Royal Bank of Canada [2025-06-30] DFND 11,803,502 12,420,999
Wells Fargo & Company/MN [2025-06-30] DFND 2,632,092 11,528,888
D. E. Shaw & Co., Inc. [2025-06-30] DFND 11,254,187 11,483,889
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 7,767,028 10,962,726
Prev | Page 4 | Next
Terms | Privacy | Guide
tony@aum13f.com